Stocktoria
BIO-PATH HOLDINGS, INC. BPTH
OTC · stock · Pharmaceutical Preparations · website · IPO 2006-01-11
BIO-PATH HOLDINGS, INC. financials (annual, from 10-K)
Bars are annual figures from 2015 to 2024; red bars are negative (a loss or cash outflow).
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — | $0 | $37,000 | $13,000 | $0 |
| R&D expense | $7.3M | $11.6M | $9.2M | $5.9M | $6.6M | $4.6M | $4.6M | $5.5M | $5.5M | $3.0M |
| Operating income | -$12.0M | -$15.8M | -$13.9M | -$10.4M | -$10.9M | -$8.7M | -$8.6M | -$9.0M | -$8.5M | -$5.5M |
| Income tax | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Net income | -$9.9M | -$16.1M | -$13.9M | -$10.4M | -$10.9M | -$8.6M | -$8.6M | -$7.0M | -$6.8M | -$5.5M |
| EPS (diluted) | $-4.12 | $-33.63 | $-38.12 | $-1.55 | $-2.83 | — | — | — | — | — |
| Operating cash flow | -$10.6M | -$11.5M | -$15.1M | -$9.9M | -$11.0M | -$8.4M | -$6.1M | -$8.0M | -$8.1M | -$5.0M |
| Free cash flow | — | — | -$15.1M | -$10.0M | — | -$8.4M | -$6.1M | -$8.5M | -$8.5M | -$5.0M |
| Total assets | $3.9M | $3.2M | $16.0M | $26.6M | $16.5M | $22.7M | $2.5M | $8.9M | $12.2M | $10.8M |
| Total liabilities | $3.7M | $2.8M | $1.8M | $1.1M | $1.4M | $1.6M | $1.3M | $791,000 | $4.0M | $937,000 |
| Shareholders' equity | $154,000 | $441,000 | $14.2M | $25.5M | $15.1M | $21.1M | $1.2M | $8.1M | $8.2M | $9.8M |
Growth · year-over-year
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue growth | — | — | — | — | — | — | -100.0% | +184.6% | — | — |
Each column is the change versus the prior fiscal year. Growth off a negative or zero base is shown as “—”. CAGR is the compound annual revenue growth across the years shown.
Source: SEC EDGAR filings · CIK 0001133818 · US · as of 2024-12-31. facts plus Stocktoria's own computed scores — not investment advice.